ZFP64 and neoplasm: Based on the ChIP-seq and promoter luciferase activity analyses, ZFP64 activated Gal-1 transcription by binding to the Gal-1 promoter, which induced cellular acquisition of the CSC phenotype and established an immunosuppressive tumor microenvironment.